Characterization of placental cholesterol transport: ABCA1 is a potential target for in utero therapy of Smith-Lemli-Opitz syndrome
Open Access
- 21 August 2008
- journal article
- research article
- Published by Oxford University Press (OUP) in Human Molecular Genetics
- Vol. 17 (23) , 3806-3813
Abstract
Patients with Smith–Lemli–Opitz syndrome (SLOS) are born with multiple congenital abnormalities. Postnatal cholesterol supplementation is provided; however, it cannot correct developmental malformations due to in utero cholesterol deficit. Increased transport of cholesterol from maternal to fetal circulation might attenuate congenital malformations. The cholesterol transporters Abca1, Abcg1, and Sr-b1 are present in placenta; however, their potential role in placental transport remains undetermined. In mice, expression analyses showed that Abca1 and Abcg1 transcripts increased 2–3-fold between embryonic days 13.5 and 18.5 in placental tissue; whereas, Sr-b1 expression decreased. To examine the functional role of Abca1, Abcg1 and Sr-b1 we measured the maternal–fetal transfer of 14C-cholesterol in corresponding mutant embryos. Disruption of either Abca1 or Sr-b1 decreased cholesterol transfer by ∼30%. In contrast, disruption of the Abcg1 had no effect. Treatment of pregnant C57Bl/6 female mice with TO901317, an LXR-agonist, increased both Abca1 expression and maternal–fetal cholesterol transfer to the fetus. In an SLOS mouse model (Dhcr7−/−), which is incapable of de novo synthesis of cholesterol, in utero treatment with TO901317 resulted in increased cholesterol content in Dhcr7−/− embryos. Our data support the hypothesis that Abca1, and possibly Sr-b1, contributes to transport maternal cholesterol to the developing fetus. Furthermore, we show, as a proof of principle, that modulating maternal–fetal cholesterol transport has potential for in utero therapy of SLOS.Keywords
This publication has 53 references indexed in Scilit:
- Enhanced placental cholesterol efflux by fetal HDL in Smith–Lemli–Opitz syndromeMolecular Genetics and Metabolism, 2008
- Smith–Lemli–Opitz syndrome: pathogenesis, diagnosis and managementEuropean Journal of Human Genetics, 2008
- Combined deficiency of ABCA1 and ABCG1 promotes foam cell accumulation and accelerates atherosclerosis in miceJournal of Clinical Investigation, 2007
- Placental ABCA1 Expression is Reduced in Primary Antiphospholipid Syndrome Compared to Pre-eclampsia and ControlsPlacenta, 2007
- PXR induces CYP27A1 and regulates cholesterol metabolism in the intestineJournal of Lipid Research, 2007
- Regulatory effects of synthetic liver X receptor- and peroxisome-proliferator activated receptor agonists on sterol transport pathways in polarized cerebrovascular endothelial cellsThe International Journal of Biochemistry & Cell Biology, 2006
- Placental expression of the nuclear receptors for oxysterols LXRα and LXRβ during mouse and human developmentThe Anatomical Record Part A: Discoveries in Molecular, Cellular, and Evolutionary Biology, 2005
- Tissue-specific autoregulation of the LXRα gene facilitates induction of apoE in mouse adipose tissueJournal of Lipid Research, 2004
- Transport of lipids from Golgi to plasma membrane is defective in Tangier disease patients and Abc1-deficient miceNature Genetics, 2000
- Cholesterol kinetics in subjects with bile fistula. Positive relationship between size of the bile acid precursor pool and bile acid synthetic rate.Journal of Clinical Investigation, 1993